Boston Scientific is Thursday's IBD Stock Of The Day. Shares are forming a double-bottom base, while approaching an early entry.

In these videos, Sushila Dulal, MD, associate professor of medicine at the University Chicago of Medicine, discusses the latest treatments, state of the pipeline and unmet needs for patients with ...

Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...

Upadacitinib showed promising results in achieving clinical and endoscopic remission in people with moderate to severe Crohn ...

Obesity is linked to lower steroid-free clinical remission rates in patients with inflammatory bowel disease, a recent study ...

A substantial proportion of patients with inflammatory bowel disease have avoidant/restrictive food intake disorder even when ...

Nikhil Jayswal, diagnosed with Crohn's disease at 20, faced colectomy and later, cancer. Battling severe health issues and ...

Netflix is the IBD Stock Of The Day as shares of the streaming video leader surged into a buy zone a day after showing ...

U.S. Treasury Secretary Scott Bessent made remarks about the unsustainable U.S.-China trade war, leading to a significant but ...

ST. LOUIS — Independent Bookstore Day will be held on Saturday, April 26, and bookstores around the St. Louis area are ...

As we look towards the future, it’s not just the technological landscape that’s evolving rapidly; our understanding of complex health issues is also undergoing a significant transformation. One such ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis ...